SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 6th, 2020 • Brainstorm Cell Therapeutics Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 6th, 2020 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of March 6, 2020, between Brainstorm Cell Therapeutics Inc., a Delaware corporation (the “Company”), and Abbhi Investments, LLC, a Delaware limited liability company (the “Purchaser”).